The Staging Option and Drug Development

Author

Neal A. Lewis
David Lee Enke, Missouri University of Science and TechnologyFollow
David Spurlock, Missouri University of Science and TechnologyFollow

Abstract

This article investigates the staging option to analyze an existing case study that involves the potential licensing of a drug compound that is in development. It demonstrates how options analysis is a useful tool in adding insight to the decision making process when conventional valuation methods are not decisive.

Recommended Citation

N. A. Lewis et al., "The Staging Option and Drug Development," Pharmaceutical Engineering, vol. 25, no. 6, pp. 58-66+76-78 - 58, International Society of Pharmaceutical Engineering (ISPE), Nov 2005.

Department(s)

Engineering Management and Systems Engineering

Keywords and Phrases

Cost Benefit Analysis; Decision Making; Depression; Drug Formulation; Drug Industry; Financial Management; Licensing; Mathematics; Review; Staging; Weight Reduction

International Standard Serial Number (ISSN)

0273-8139

Document Type

Article - Journal

Document Version

Citation

File Type

text

Language(s)

English

Rights

© 2005 International Society of Pharmaceutical Engineering (ISPE), All rights reserved.

Publication Date

01 Nov 2005